Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)
- PMID: 30910047
- DOI: 10.1016/j.ophtha.2018.11.004
Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)
Comment in
-
Reply.Ophthalmology. 2019 Apr;126(4):e30-e31. doi: 10.1016/j.ophtha.2018.11.005. Ophthalmology. 2019. PMID: 30910048 No abstract available.
Comment on
-
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial.Ophthalmology. 2018 Oct;125(10):1547-1555. doi: 10.1016/j.ophtha.2018.04.021. Epub 2018 Jun 14. Ophthalmology. 2018. PMID: 29776672 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources